Previous Article | Next Article 
Journal of Virology, September 1999, p. 7132-7137, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
The Presence of Human Immunodeficiency Virus Type 1 Vpr Correlates with a Decrease in the Frequency of Mutations in a
Plasmid Shuttle Vector
Jeremy B.
Jowett,1,2
Yi-ming
Xie,1 and
Irvin
S. Y.
Chen1,*
Departments of Microbiology & Immunology and
Medicine, University of California
Los Angeles School of Medicine, Los
Angeles, California 90095-1678,1 and
International Diabetes Institute, Caulfield, Victoria 3162, Australia2
Received 21 January 1999/Accepted 3 May 1999
 |
ABSTRACT |
The human immunodeficiency virus type 1 (HIV-1) Vpr protein induces
cell cycle arrest at the border of G2 and M similar to the
arrest caused by agents which damage DNA. We determined whether the
presence of Vpr would affect the ability of cells to repair DNA. We
developed a shuttle vector system to analyze the effect of Vpr upon the
repair of UV-damaged DNA. Our results demonstrated that the presence of
Vpr decreased the rate of deletions in this system. Of note, cells
arrested in G2 by other genotoxic agents also increased the
frequency of DNA repair of UV-damaged shuttle vectors. We did not
observe any direct effect of Vpr upon the rate of double-strand break
repair and/or nucleotide excision repair of genomic DNA in cells. Our
results suggest a role for HIV-1 Vpr in altering the frequency of DNA
repair, a property which may have importance for HIV-1 replication and pathogenesis.
 |
INTRODUCTION |
The genome of human immunodeficiency
virus (HIV), the etiological agent of AIDS, contains nine genes, five
of which have been determined to be essential for replication in vitro.
The remaining four genes, vpr, vpu,
vif, and nef, have consequently been dubbed nonessential accessory genes, and they play various roles, either directly, in enhancing the efficiency of the replication cycle of HIV,
or indirectly, in enhancing survival in the presence of the immune
system in vivo and potentially in the causation of disease (10,
11, 27).
Vpr encodes an 11-kDa protein that is incorporated into the virion via
an interaction with the carboxy-terminal portion of the Gag precursor
protein (17). Vpr has been proposed to promote nuclear
localization of the viral preintegration complex following infection
(5, 15), although this role has been disputed
(13). This function of Vpr has been suggested to increase
the efficiency of replication of HIV in nondividing cells (3,
7). Furthermore, Vpr has been ascribed additional roles in
enhancement of transcriptional activity on various promoters, including
the HIV long terminal repeat (6), and in the rescue of viral
expression from latently infected cell lines (20), although
the roles of these effects on the viral life cycle have yet to be determined.
We and others have reported that the HIV type 1 (HIV-1) vpr
gene product causes cell cycle arrest in HIV-infected target cells (14, 16, 32, 33). We further proposed that cell cycle arrest
induced by Vpr may play a role in pathogenesis by inhibiting the clonal
expansion and effective immune response of T cells (16, 31).
Phenotypic characterization of the Vpr-mediated arrest revealed that
the cells arrested in the second gap (G2) phase of the cell
cycle, prior to initiation of mitosis (M). The Cdc2 kinase, a major
component controlling the transition of cells from G2 to M,
was found to be predominantly in the inactive state (16, 30). This point of arrest can also be triggered in a cell
following certain types of DNA damage. Alkylating agents and ionizing
radiation cause cells to arrest or delay in G2 and prevent
or postpone the onset of mitosis, depending upon the severity of the
damage. This pause in cell cycle progression has been suggested as a
period in which repair to the DNA is carried out, after which the cell resumes cell cycle progression into mitosis (21, 24, 26). We
identified a phenotypic similarity between Vpr-mediated cell cycle
arrest and arrest caused by DNA-damaging agents (30). The
attributes identified included growth arrest in the G2
phase of the cell cycle with hyperphosphorylation of Cdc2 kinase and the ability of methylxanthines to reverse cell cycle arrest by both Vpr
and nitrogen mustard. We proposed, therefore, that Vpr may mediate
growth arrest either through (i) directly causing DNA damage, (ii)
interfering with DNA damage repair processes, or (iii) modulating a DNA
damage detection pathway (checkpoint). In this study we determined
whether the presence of Vpr influences the rate of DNA damage and
repair in cells. We examined the effect of Vpr on both cellular DNA and
exogenously introduced nonviral templates.
Our results indicate that the presence of Vpr results in a reduction in
the frequency of deletions in a shuttle vector system. Vpr, however,
did not detectably affect nucleotide excision repair or double-strand
break repair on cellular DNA.
 |
MATERIALS AND METHODS |
Cells and viral stocks.
COS cells (African green monkey
kidney) were grown in Dulbecco's modified Eagle's medium with 10%
calf serum (Gemini). Stocks of HIV-1NL4-3-thy
env(
)/vesicular stomatitis virus G protein (VSV-G) and
HIV-1NL4-3-thyvprXenv(
)/VSV-G were prepared and used to
infect target cells as previously described (30). The
measurement of levels of infection was performed with anti-Thy 1.2 antibodies and flow cytometry as described previously (16).
In the case where Vpr was provided in the absence of all other HIV
proteins, the vector NLthy
Bgl was replaced with both
pHRcmvypyvpr and pCMVdR8.2DVPR, which made up the viral stock pHRVpr.
The former was derived from pHRcmvluciferase (25) by removal
of the luciferase open reading frame and substitution with the
epitope-tagged vpr open reading frame. As a control for this
experiment, an additional vector was constructed, pHRcmvthy, which was
identical to pHRcmvypyvpr except that the murine thy1.2 gene
(29) replaced the vpr open reading frame (giving the viral
stock pHRThy). The latter plasmid, pCMVdR8.2DVPR, was used as a
packaging plasmid based on pCMVdR8.2D (25), but with the
vpr open reading frame deleted. The R80A mutant of Vpr,
prepared in the NLthy
Bgl vector, consists of a single-amino-acid
change at codon 80 from arginine to alanine and is identical to the
mutant previously described (8).
Shuttle vector.
The shuttle vector used in these DNA damage
detection experiments was the pBK-CMV (pBK) phagemid vector obtained
from Stratagene. Where stated, the plasmid was irradiated in Tris-EDTA
buffer (pH 7.5) on parafilm in a Stratalinker UV light irradiator at a
rate of approximately 6 J/s. At 16 h postinfection, to allow
reverse transcription, integration, and expression of viral proteins, the cells were transfected with the pBK shuttle vector by using Lipofection (Life Technologies) according to the manufacturer's protocol. The cells were harvested after a further 48 h (allowing maximal episomal replication of the plasmid) and lysed, and a Hirt
extraction was performed to recover low-molecular-weight DNA. The
recovered DNA was transformed into Escherichia coli and plated on nutrient medium. Colonies were scored after overnight incubation at 37°C and a further 4- to 6-h incubation at 4°C to enhance the blue color. Linearized shuttle vector was prepared by
digestion with HindIII, which cuts within the LacZ
peptide coding region.
CHEF pulsed-field gel electrophoresis.
The method and
reagents used for contour-clamped homogeneous electric field (CHEF)
pulsed-field gel electrophoresis were derived from the CHEF genomic DNA
plug kit (Bio-Rad). Briefly, cells were harvested with trypsin, washed,
and set in a 2% soft agar plug at 2 × 106 to 3 × 106/ml. The plugs were digested overnight at 50°C with
proteinase K (1 mg/ml) and then washed four times in wash buffer. The
agarose plugs were then set in the electrophoresis gel (1%) and
subjected to CHEF pulsed-field electrophoresis in 0.25×
Tris-borate-EDTA buffer as follows: initial pulse time, 60 s;
final pulse time, 120 s; field strength, 5.2 V/cm; duration,
22.5 h. These settings resolve fragments less than approximately 2 Mbp; the larger fragments will migrate in a "compression" zone at
the same point, while unbroken genomic DNA remains at the origin
(4, 18).
Unscheduled DNA synthesis (UDS) assay.
Cells were infected
as described above. A strong inhibitor of replicative DNA synthesis
(hydroxyurea [10 mM]) was added 1 h prior to UV irradiation (30 J/m2). The use of this inhibitor is required because of the
potential for high levels of background [3H]thymidine
incorporation as the cells progress through DNA synthesis (S) phase.
Immediately following UV irradiation, [3H]thymidine was
added to the tissue culture medium (50 µCi/ml) and pulsed for a
further 2 h in the presence of hydroxyurea. The cells were
harvested and lysed on a filter prior to being immersed in
scintillation fluid and counted. The values reported are the means of
triplicate samples.
Statistical analysis.
Statistical significance (where
indicated) was calculated by either the chi-square test or Fisher's
exact test (two-tailed method).
 |
RESULTS |
Vpr decreases DNA mutation frequency in a transfected shuttle
vector.
To investigate whether Vpr affects the repair of damaged
DNA, we utilized a shuttle vector (pBK) containing the
lacZ
gene under the control of a bacterial promoter as a
reporter gene for mutation. When transformed into E. coli,
the colonies turn blue in the presence of inducer and substrate. A
white colony would indicate a mutation in either the LacZ
peptide
reporter gene or in its expression control regions. The vector also
contained a eukaryotic origin of replication derived from simian virus
40 (SV40) allowing episomal replication in COS cells to sufficiently high levels for detection after extraction and transformation into
bacteria. We first determined conditions which would provide a
sufficiently high rate of mutation for us to monitor the effects of
Vpr. We found that UV irradiation of plasmid DNA at a dose of 2,500 J/m2 followed by DNA transfection and recovery after
48 h was sufficient to achieve a mutation frequency of
approximately 3%.
We determined the effect of Vpr on the mutation frequency by expressing
Vpr in cells prior to transfection with the reporter plasmid. COS cells
were infected at a high multiplicity of infection with a pseudotyped
virus based on the HIV-1NL4-3 strain carrying either a
wild-type Vpr [HIV-1NL4-3-thyenv(
)/VSV-G] or a
frame-shifted mutant of Vpr, termed VprX
[HIV-1NL4-3-thyvprXenv(
)/VSV-G] that results in
truncation of approximately one-third of the protein (16,
29). A sufficient innoculum of virus was used to ensure that more
than 90% of the cells were infected, which was verified by Thy 1.2 expression and flow cytometry (data not shown). The mutant protein does
not induce G2 cell cycle arrest. At 16 h after infection, the cells were transfected with the pBK shuttle vector and
harvested after a further 48 h. The recovered episomal DNA was
transformed into E. coli, and the blue and white colonies were counted. The presence of Vpr reduced the mutation frequency occurring at the lacZ gene locus by approximately 10-fold
compared to that of mock- or VprX-infected cells (Table
1). Although the magnitude varied in
different experiments, a 10-fold or greater level of reduction of the
mutation frequency of the shuttle vector was consistently observed with
Vpr.
We confirmed that the effect was due specifically to Vpr by using a
point mutant of Vpr (R80A) that is expressed stably yet
fails to cause
cell cycle arrest (
8). We found that VprR80A
resulted in a
mutation frequency in our shuttle vector (2.6%)
similar to that of
mock-infected COS cells (2.9%), while wild-type
Vpr resulted in a
0.16% mutation frequency (Table
2).
We verified that Vpr alone was the cause of the observed reduction in
mutation frequency and that it was not a result of other
viral proteins
present in the NL-Thy vector. We prepared a retroviral
vector capable
of only Vpr production following infection (pHRVpr).
The level of
suppression was approximately 10-fold that of the
control (pHRThy) and
was similar to that obtained with virus carrying
the wild-type
vpr gene (Table
3).
Vpr reduces the frequency of deletion mutants.
Plasmids were
recovered from randomly selected white colonies and analyzed by
nucleotide sequence analysis for the type of mutation that abolishes
LacZ
peptide function. All of the mutations were found to be
deletions in the lacZ
peptide open reading frame and/or
its promoter region (data not shown).
Deletions in DNA may arise when a double-strand DNA break occurs,
followed by exonuclease digestion and end rejoining, with
the size of
the deletion determined by the level of exonuclease
activity and the
rate of end ligation. Alternatively, a deletion
may occur when
recombination takes place between two homologous
regions of DNA. The
size of this deletion is determined by the
size of the intervening DNA
segment between the homologous regions.
Deletion junctions in a random
selection of recovered mutant shuttle
vectors derived from mock, Vpr-,
and VprX-containing cultures
were examined by nucleotide sequence
analysis for evidence of
homologous recombination. We found that the
sizes of the deletions
varied from one plasmid to the next and that
there were no obvious
stretches of homology at or near the deletion
junctions that would
be indicative of homologous recombination (data
not shown). This
observation is consistent with published work with
similar shuttle
vector systems (
9).
Vpr reduces mutation frequency in the repair of linearized shuttle
vector DNA.
The above results indicate that deletion mutants could
result from cleavage of DNA followed by nuclease activity. We therefore tested whether Vpr could affect mutation frequency in the shuttle vector cleaved by a restriction endonuclease. The shuttle vector was
digested to completion with an enzyme that cuts once within the
lacZ
peptide coding region. We observed overall a higher frequency of white colonies, as might be expected following
transfection of linearized plasmid DNA. As expected, nucleotide
sequence analysis of white colonies demonstrated evidence for deletions
extending from the cleavage site. We found that the presence of Vpr in
this experiment decreased the frequency of mutation by approximately two- to threefold compared to that of either mock-infected or VprX
virus-infected cells (Table 4). This
result suggested that the presence of Vpr reduces the mutation
frequency during the repair and recircularization of linear DNA. One
interpretation is that the presence of Vpr facilitates accurate end
rejoining of double-strand breaks in DNA. Alternatively, the presence
of Vpr may inhibit double-strand break rejoining. Since plasmids with
double-strand breaks would not amplify in COS cells, any plasmids
bearing mutations originating from a double-strand break would not be
detected.
Vpr does not directly affect endogenous cellular DNA repair
processes.
The above observations are consistent with the idea
that the presence of Vpr acts to increase the rate of ligation, thereby preventing the action of nucleases on the free DNA ends; to inhibit cellular exonuclease digestion of free ends; or to inhibit rejoining of
double-strand breaks. We tested the possibility that Vpr influences the
ability of cellular DNA to repair itself. We measured the rate of
endogenous DNA repair either in the presence or absence of Vpr
following the generation of double-strand breaks by
-irradiation. Pulsed-field gel electrophoresis was used to monitor strand breakage and its rate of repair (2, 18). Vpr did not itself cause detectable levels of double-strand DNA breaks (Fig.
1).
-Irradiation (80 Gy) caused
double-strand breakage as measured by the appearance of a
lower-molecular-weight band on a pulsed-field gel (Fig. 1). The DNA was
repaired completely by 240 min following irradiation, as evidenced by
the diminishing intensity of the faster-migrating band over time, as
has been previously described (18). In the presence of Vpr,
the faster-migrating band diminished at a similar rate, indicating that
Vpr did not alter the rate of repair of the double-strand DNA breaks
induced by irradiation. Thus, within the limits of this assay, we
conclude that Vpr does not detectably enhance or inhibit the rate of
repair of double-strand breaks generated by
-irradiation.
Furthermore, the presence of Vpr itself does not induce double-strand
breaks in DNA. However, we could not determine from this experiment
whether the presence of Vpr affects the rate of mutation at or around
the breakpoint junctions.

View larger version (49K):
[in this window]
[in a new window]
|
FIG. 1.
Vpr does not affect rate of endogenous DNA double-strand
break repair induced by -irradiation. COS cells (6 × 105) were infected with
HIV-1NL4-3-thyenv( )/VSV-G (Vpr) to give a >90%
infection rate as measured by Thy expression at 48 h
postinfection. At 18 h postinfection, the cells were exposed to 80 Gy of -irradiation and harvested at the indicated time points. The
cells were embedded in 1% soft agarose, gently lysed, and subjected to
pulsed-field electrophoresis at 5.1 V/cm and 60- to 120-s ramp time for
22 h. Lane Y, Saccharomyces cerevisiae chromosomes were
used as markers, with the sizes indicated.
|
|
Different repair pathways are utilized by the cell to repair DNA
damage, depending upon the nature of the damage to the DNA.
Nucleotide
excision repair (NER) is the primary mechanism active
in repair of
cyclobutane pyrimidine dimers, the primary form of
damage caused by UV
light irradiation. Vpr has been shown to bind
to HHR23A
(
36), a protein that can bind xeroderma
pigmentosum-complementing
protein group C (XPC). XPC likely plays a
role in NER, although
its function has not yet been determined (
1,
23). A part
of normal NER activity is in the resynthesis of the
damaged stretch
of DNA by using the complementary strand as a template.
This has
been called UDS and can be measured in cells following UV
irradiation
by using radioactively labeled nucleotides (
12,
34). To test
whether Vpr could affect NER, we measured UDS in
UV-irradiated
cells in the presence and absence of Vpr. UDS was seen as
an increase
in [
3H]thymidine incorporation following UV
irradiation. Mock-infected
and VprX-infected cells showed approximately
a twofold increase
in [
3H]thymidine incorporation
following UV irradiation (Table
5).
No
significant difference was observed in cells expressing Vpr.
Thus,
these results indicate that Vpr does not grossly affect
the extent of
repair synthesis; however, the fidelity of the repair
synthesis cannot
be assessed by these experiments.
Agents that damage cellular DNA can also decrease shuttle vector
mutation frequency.
The similarities between Vpr-mediated
G2 cell cycle arrest and the cell cycle arrest induced by
DNA-damaging agents suggest that Vpr triggers a normal cellular
checkpoint activated in response to damage of the DNA. These
checkpoints are normally activated in order to allow cells to repair
damaged DNA prior to further progression through the cell cycle
(21, 24, 26). It is conceivable that activation of the
checkpoint would also activate DNA repair processes which have high
fidelity for repair of damaged DNA. Such a scenario has been observed
following the activation of p53, which, among other effects, induces
cell cycle arrest at the G1/S phase and simultaneously
activates GADD45, a protein involved in NER (19, 35). An
increase in resistance to UV light damage in G2 versus
G1 has been studied in a synchronized cell population. This
difference, however, was attributed to an increased time for repair in
G2 until the beginning of the next S phase rather than a
specific activation of DNA repair enzymes (28).
Since Vpr alters the frequency of mutation, we determined whether the
arrest of cells by other genotoxic agents might have
similar effects on
the frequency of mutation. COS cells were treated
with agents known to
cause double-strand DNA breaks and cell cycle
arrest in the
G
2 phase of the cell cycle. These were

-irradiation
(40 Gy), cisplatin (300 µM; 1 h), and nitrogen mustard (25 µM;
30 min). Treatment with UV irradiation (30 J/m
2) was also
included, as it generates a different set of lesions,
the majority of
which are cyclobutane pyrimidine dimers. Compared
to mock-treated
samples, all treatments caused a decrease in mutation
frequency in the
transfected shuttle vector ranging from fourfold
to ninefold (Table
6). This data suggests that a common
mechanism
of action may exist for Vpr and other genotoxic agents in the
reduction of mutation frequency. One possibility is that both
Vpr and
DNA damage activate common checkpoint pathways which alter
the
frequency of DNA repair.
 |
DISCUSSION |
Our results demonstrate that the presence of HIV-1 Vpr acts to
decrease the frequency of deletion mutations which occur following introduction of a UV-damaged plasmid into cells. Since Vpr induces cell
cycle arrest at a G2 checkpoint, we determined whether Vpr directly affects the repair of damage to endogenous cell DNA. However,
we observed no effect of Vpr upon the rate of either double-strand-break repair or NER of cellular DNA. The effects of Vpr
on mutation rates were similar to that observed with other agents which
induce cell cycle arrest, such as
radiation and DNA-damaging chemicals.
It is noteworthy that a previous study (22) reported that
Vpr could reduce the mutation rate of an HIV-1 shuttle vector by
approximately fourfold. The design of the experiments suggested that
the mutations that were observed were a result of errors that occurred
during reverse transcription. The mutations which we monitored in our
experiments were a result of cellular DNA damage repair processes in
which reverse transcription is not implicated. The majority of the
mutations we observed, both in the presence and absence of Vpr, were
deletions, consistent with previous reports of the major types of
mutations occurring following transfection of DNA into cells. The most
likely mechanism for deletion formation is a double-strand break in the
DNA followed by nuclease activity and religation of the free DNA ends.
Vpr could decrease the frequency of mutations by (i) increasing the rate of accurate rejoining of DNA following breakage, (ii) decreasing the rate of rejoining of ends resulting from double-strand breaks (resulting in failure to amplify in COS cells), (iii) increasing the
fidelity of nucleotide excision repair of UV-damaged plasmids such that
double-strand breaks are less likely to occur, (iv) inhibiting the
action of nucleases on the broken free ends of DNA, and (v) enhancing
the activity of error-free as opposed to error-prone mechanisms of DNA
repair. From our experiments, we cannot distinguish among the above
possibilities; however, altering the rate of rejoining of double-strand
breaks (hypotheses i and ii above) appears less likely, since we did
not observe an effect of Vpr on repair of double-strand breaks induced
by
-irradiation of endogenous cellular DNA. If one assumes that the
increase in fidelity in our studies is due to mechanisms similar to
those in the studies by Mansky (22), as-yet-unknown
processes involved in DNA repair common to cellular DNA repair and
reverse transcription may be implicated.
We hypothesize that Vpr acts along pathways normally used by cells to
induce cell cycle arrest at a G2 checkpoint. These
checkpoints are ordinarily activated in cells following damage by
genotoxic agents, such as
radiation, which induces double-strand
breaks in DNA. Failure to arrest at G2 and entry into
mitosis without repair of double-strand breaks would have catastrophic
consequences for the ability of the cell to faithfully duplicate its
genetic material in daughter cells. Since it is so critical for a cell to faithfully replicate and segregate DNA, it is conceivable that activation of DNA repair processes which are more efficient or act with
greater fidelity occurs at the G2 checkpoint. In this scenario, the mechanism by which Vpr decreases the frequency of mutations is not a direct effect of Vpr but rather a consequence of the
cell cycle arrest checkpoint induced by Vpr. A similar decrease in the
frequency of mutations observed in cells arrested by other genotoxic
agents is consistent with this idea.
We have proposed previously that one important consequence of Vpr
action is the crippling of an effective immune response through
arresting division of antigen-activated T cells. The results discussed
here suggest the hypothesis that enhancing the fidelity of DNA repair
may be another function of Vpr important for HIV-1 replication or
pathogenesis. As described by Mansky (22), Vpr may act to
increase the fidelity of reverse transcription. We demonstrated
previously that Vpr packaged within virions is sufficient to induce
cell cycle arrest during the initial infection (31). Thus,
another point in the viral life cycle where enhanced fidelity of DNA
repair could play a role is during integration. Based upon our results,
we hypothesize that Vpr may act to facilitate integration by creating
an environment within the cell or in the context of the preintegration
complex which facilitates integration. One possibility may be to
protect the free ends of unintegrated viral DNA from nucleases, akin to
our proposed mechanism for reducing deletions in our transfected
shuttle vector. Another possibility may be to enhance the rate of
ligation of free viral DNA ends to endonuclease-cleaved cellular DNA.
Vpr may therefore promote HIV evasion of possible intracellular
defenses against exogenous DNA sequences entering the cell. We can test
these possibilities by examining the effect of Vpr on the rate of
integration and the structures of preintegration viral DNA intermediates.
 |
ACKNOWLEDGMENTS |
We thank Elizabeth Withers-Ward and Kathie Grovit-Ferbas for
critical reading of the manuscript and Liz Duarte and Rosie Taweesup for preparation of the manuscript. We are grateful to Dong Sung An for
preparation of the pCMVdR8.2DVPR and the pHRcmvthy vectors and to
Sheila Stewart for preparation of the pHRcmvypyvpr vector and R80A
point mutant of Vpr used in this study.
This work is supported by NIH grant CA70018, The Center for AIDS
Research (CFAR), and Amgen. J.B.J. was supported by an American Cancer
Society Fellowship.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Departments of
Microbiology & Immunology and Medicine, UCLA School of Medicine, Los Angeles, CA 90095-1678. Phone: (310) 825-4793. Fax: (310) 794-7682. E-mail: rtaweesu{at}ucla.edu.
 |
REFERENCES |
| 1.
|
Aboussekhra, A., and R. D. Wood.
1994.
Repair of UV-damaged DNA by mammalian cells and Saccharomyces cerevisiae.
Curr. Opin. Genet. Dev.
4:212-220[Medline].
|
| 2.
|
Ager, D. D., and W. C. Dewey.
1990.
Calibration of pulsed field gel electrophoresis for measurement of DNA double-strand breaks.
Int. J. Radiat. Biol.
58:249-259[Medline].
|
| 3.
|
Balliet, J. W.,
D. L. Kolson,
G. Eiger,
F. M. Kim,
K. A. McGann,
A. Srinivasan, and R. Collman.
1994.
Distinct effects in primary macrophages and lymphocytes of the human immunodeficiency virus type 1 accessory genes vpr, vpu, and nef: mutational analysis of a primary HIV-1 isolate.
Virology
200:623-631[Medline].
|
| 4.
|
Blèocher, D.,
M. Einspenner, and J. Zajackowski.
1989.
CHEF electrophoresis, a sensitive technique for the determination of DNA double-strand breaks.
Int. J. Radiat. Biol.
56:437-448[Medline].
|
| 5.
|
Bukrinsky, M. I.,
S. Haggerty,
M. P. Dempsey,
N. Sharova,
A. Adzhubel,
L. Spitz,
P. Lewis,
D. Goldfarb,
M. Emerman, and M. Stevenson.
1993.
A nuclear localization signal within HIV-1 matrix protein that governs infection of non-dividing cells.
Nature
365:666-669[Medline].
|
| 6.
|
Cohen, E. A.,
E. F. Terwilliger,
Y. Jalinoos,
J. Proulx,
J. G. Sodroski, and W. A. Haseltine.
1990.
Identification of HIV-1 vpr product and function.
J. Acquired Immune Defic. Syndr.
3:11-18.
|
| 7.
|
Connor, R. I.,
B. K. Chen,
S. Choe, and N. R. Landau.
1995.
Vpr is required for efficient replication of human immunodeficiency virus type-1 in mononuclear phagocytes.
Virology
206:935-944[Medline].
|
| 8.
|
Di Marzio, P.,
S. Choe,
M. Ebright,
R. Knoblauch, and N. R. Landau.
1995.
Mutational analysis of cell cycle arrest, nuclear localization, and virion packaging of human immunodeficiency virus type 1 Vpr.
J. Virol.
69:7909-7916[Abstract].
|
| 9.
|
DuBridge, R. B., and M. P. Calos.
1988.
Recombinant shuttle vectors for the study of mutation in mammalian cells.
Mutagenesis
3:1-9[Free Full Text].
|
| 10.
|
Fauci, A. S.
1988.
The human immunodeficiency virus: infectivity and mechanisms of pathogenesis.
Science
239:617-622[Abstract/Free Full Text].
|
| 11.
|
Fauci, A. S.
1993.
Multifactorial nature of human immunodeficiency virus disease: implications for therapy.
Science
262:1011-1018[Abstract/Free Full Text].
|
| 12.
|
Fautz, R.,
B. Husein,
E. Efstathiou, and C. Hechenberger-Freudl.
1993.
Assessment of the relation between the initial viability and the attachment of freshly isolated rat hepatocytes used for the in vivo/in vitro DNA repair assay (UDS).
Mutat. Res.
291:21-27[Medline].
|
| 13.
|
Freed, E. O.,
G. Englund, and M. A. Martin.
1995.
Role of the basic domain of human immunodeficiency virus type 1 matrix in macrophage infection.
J. Virol.
69:3949-3954[Abstract].
|
| 14.
|
He, J.,
S. Choe,
R. Walker,
P. Di Marzio,
D. O. Morgan, and N. R. Landau.
1995.
Human immunodeficiency virus type 1 viral protein R (Vpr) arrests cells in the G2 phase of the cell cycle by inhibiting p34cdc2 activity.
J. Virol.
69:6705-6711[Abstract].
|
| 15.
|
Heinzinger, N. K.,
M. I. Bukrinsky,
S. A. Haggerty,
A. M. Ragland,
V. Kewalramani,
M. A. Lee,
H. E. Gendelman,
L. Ratner,
M. Stevenson, and M. Emerman.
1994.
The Vpr protein of human immunodeficiency virus type 1 influences nuclear localization of viral nucleic acids in nondividing host cells.
Proc. Natl. Acad. Sci. USA
91:7311-7315[Abstract/Free Full Text].
|
| 16.
|
Jowett, J. B.,
V. Planelles,
B. Poon,
N. P. Shah,
M. L. Chen, and I. S. Y. Chen.
1995.
The human immunodeficiency virus type 1 vpr gene arrests infected T cells in the G2 + M phase of the cell cycle.
J. Virol.
69:6304-6313[Abstract].
|
| 17.
|
Kondo, E.,
F. Mammano,
E. A. Cohen, and H. G. Göttlinger.
1995.
The p6gag domain of human immunodeficiency virus type 1 is sufficient for the incorporation of Vpr into heterologous viral particles.
J. Virol.
69:2759-2764[Abstract].
|
| 18.
|
Lee, S. E.,
C. R. Pulaski,
D. M. He,
D. M. Benjamin,
M. Voss,
J. Um, and E. A. Hendrickson.
1995.
Isolation of mammalian cell mutants that are X-ray sensitive, impaired in DNA double-strand break repair and defective for V(D)J recombination.
Mutat. Res.
336:279-291[Medline].
|
| 19.
|
Levine, A. J.
1997.
p53, the cellular gatekeeper for growth and division.
Cell
88:323-331[Medline].
|
| 20.
|
Levy, D. N.,
Y. Refaeli,
R. R. MacGregor, and D. B. Weiner.
1994.
Serum Vpr regulates productive infection and latency of human immunodeficiency virus type 1.
Proc. Natl. Acad. Sci. USA
91:10873-10877[Abstract/Free Full Text].
|
| 21.
|
Maity, A.,
W. G. McKenna, and R. J. Muschel.
1994.
The molecular basis for cell cycle delays following ionizing radiation: a review.
Radiother. Oncol.
31:1-13[Medline].
|
| 22.
|
Mansky, L. M.
1996.
The mutation rate of human immunodeficiency virus type 1 is influenced by the vpr gene.
Virology
222:391-400[Medline].
|
| 23.
|
Masutani, C.,
K. Sugasawa,
J. Yanagisawa,
T. Sonoyama,
M. Ui,
T. Enomoto,
K. Takio,
K. Tanaka,
P. J. van der Spek,
D. Bootsma, et al.
1994.
Purification and cloning of a nucleotide excision repair complex involving the xeroderma pigmentosum group C protein and a human homologue of yeast RAD23.
Embo. J.
13:1831-1843[Medline].
|
| 24.
|
Murnane, J. P.
1995.
Cell cycle regulation in response to DNA damage in mammalian cells: a historical perspective.
Cancer Metastasis Rev.
14:17-29[Medline].
|
| 25.
|
Naldini, L.,
U. Blömer,
P. Gallay,
D. Ory,
R. Mulligan,
F. H. Gage,
I. M. Verma, and D. Trono.
1996.
In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector.
Science
272:263-637[Abstract].
|
| 26.
|
O'Connor, P. M.,
D. K. Ferris,
G. A. White,
J. Pines,
T. Hunter,
D. L. Longo, and K. W. Kohn.
1992.
Relationships between cdc2 kinase, DNA cross-linking, and cell cycle perturbations induced by nitrogen mustard.
Cell Growth Differ.
3:43-52[Abstract].
|
| 27.
|
Peterlin, B. M., and P. A. Luciw.
1988.
Molecular biology of HIV.
AIDS
2(Suppl. 1):S29-S40.
|
| 28.
|
Petersen, L. N.,
D. K. Orren, and V. A. Bohr.
1995.
Gene-specific and strand-specific DNA repair in the G1 and G2 phases of the cell cycle.
Mol. Cell. Biol.
15:3731-3737[Abstract].
|
| 29.
|
Planelles, V.,
J. B. Jowett,
Q. X. Li,
Y. Xie,
B. Hahn, and I. S. Y. Chen.
1996.
Vpr-induced cell cycle arrest is conserved among primate lentiviruses.
J. Virol.
70:2516-2524[Abstract].
|
| 30.
|
Poon, B.,
J. B. Jowett,
S. A. Stewart,
R. W. Armstrong,
G. M. Rishton, and I. S. Y. Chen.
1997.
Human immunodeficiency virus type 1 vpr gene induces phenotypic effects similar to those of the DNA alkylating agent, nitrogen mustard.
J. Virol.
71:3961-3971[Abstract].
|
| 31.
|
Poon, B.,
K. Grovit-Ferbas,
S. A. Stewart, and I. S. Y. Chen.
1998.
Cell cycle arrest by Vpr in HIV-1 virions and insensitivity to antiretroviral agents.
Science
281:266-269[Abstract/Free Full Text].
|
| 32.
|
Re, F.,
D. Braaten,
E. K. Franke, and J. Luban.
1995.
Human immunodeficiency virus type 1 Vpr arrests the cell cycle in G2 by inhibiting the activation of p34cdc2-cyclin B.
J. Virol.
69:6859-6864[Abstract].
|
| 33.
| Rogel, M. E., L. I. Wu, and M. Emerman.
1995. The human immunodeficiency virus type 1 vpr gene prevents cell
proliferation during chronic infection. 69:882-888.
|
| 34.
|
Sawada, S.,
S. Asakura,
H. Daimon, and C. Furihata.
1995.
Comparison of autoradiography, liquid scintillation counting and immunoenzymatic staining of 5-bromo-2'-deoxyuridine for measurement of unscheduled DNA synthesis and replicative DNA synthesis in rat liver.
Mutat. Res.
344:109-116[Medline].
|
| 35.
|
Smith, M. L.,
I. T. Chen,
Q. Zhan,
I. Bae,
C. Y. Chen,
T. M. Gilmer,
M. B. Kastan,
P. M. O'Connor, and A. J. Fornace, Jr.
1994.
Interaction of the p53-regulated protein Gadd45 with proliferating cell nuclear antigen.
Science
266:1376-1380[Abstract/Free Full Text].
|
| 36.
|
Withers-Ward, E. S.,
J. B. M. Jowett,
S. A. Stewart,
Y. M. Xie,
A. Garfinkel,
Y. Shibagaki,
S. A. Chow,
N. Shah,
F. Hanaoka,
D. G. Sawitz,
R. W. Armstrong,
L. M. Souza, and I. S. Y. Chen.
1997.
Human immunodeficiency virus type 1 Vpr interacts with HHR23A, a cellular protein implicated in nucleotide excision DNA repair.
J. Virol.
71:9732-9742[Abstract].
|
Journal of Virology, September 1999, p. 7132-7137, Vol. 73, No. 9
0022-538X/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Romani, B., Engelbrecht, S.
(2009). Human immunodeficiency virus type 1 Vpr: functions and molecular interactions. J. Gen. Virol.
90: 1795-1805
[Abstract]
[Full Text]
-
DeHart, J. L., Planelles, V.
(2008). Human Immunodeficiency Virus Type 1 Vpr Links Proteasomal Degradation and Checkpoint Activation. J. Virol.
82: 1066-1072
[Full Text]
-
Mansky, L. M., Preveral, S., Selig, L., Benarous, R., Benichou, S.
(2000). The Interaction of Vpr with Uracil DNA Glycosylase Modulates the Human Immunodeficiency Virus Type 1 In Vivo Mutation Rate. J. Virol.
74: 7039-7047
[Abstract]
[Full Text]
-
Zhou, Y., Ratner, L.
(2000). Phosphorylation of Human Immunodeficiency Virus Type 1 Vpr Regulates Cell Cycle Arrest. J. Virol.
74: 6520-6527
[Abstract]
[Full Text]
-
Masuda, M., Nagai, Y., Oshima, N., Tanaka, K., Murakami, H., Igarashi, H., Okayama, H.
(2000). Genetic Studies with the Fission Yeast Schizosaccharomyces pombe Suggest Involvement of Wee1, Ppa2, and Rad24 in Induction of Cell Cycle Arrest by Human Immunodeficiency Virus Type 1 Vpr. J. Virol.
74: 2636-2646
[Abstract]
[Full Text]